From deciphering underlying genetic factors of diseases to developing cutting-edge genome technology, our scientists are making impactful discoveries everyday.
Strength in Genetics and Genomics Research
The Department of Genetics has traditional strengths in computational biology and genome science, as well as model organism, evolutionary and human genetics. Recent specialties include neurological disorders, cellular bioenergetics, epigenomics, personalized medicine and genome technology development.
We have established leadership in the following flagship NIH genomic medicine themed projects:
- The Human Pangenome Project (NHGRI)
- The Impact of Genetic Variation on Function (NHGRI)
- The Long Life Family Study (NIA)
- Somatic Mosaicism across Human Tissues (NIH Common Fund)
- Multi-Omics for Health and Disease (NHGRI, NCI, NIEHS)
- The BRAIN (The Brain Research through Advancing Innovative Neurotechnologies) Initiative Cell Atlas Network (NIMH)
Within the close-knit research community of Washington University School of Medicine, our scientists are supported by a strong foundation. School of Medicine Facts & Figures
| #2 NIH Funding (2023) | $838.3 Million Research Funding 2022 | 19 Nobel Laureates |
Latest News
$14 million supports work to diversify human genome research (Links to an external site)
Washington University School of Medicine in St. Louis has received two large grants renewing funding for the Human Pangenome Reference Sequencing Project. This ambitious program began in 2019 with the goal of increasing the diversity of human genome sequences that are pooled into the widely used reference genome. A thorough representation of human genetic diversity can help researchers discover how genetic variation contributes to disease and perhaps offer new routes to innovative treatments.
Congratulations to Yung-Chun (David) Wang in the Jin lab for receiving the Center of Regenerative Medicine’s hCTO microgrant
Yung-Chun (David) Wang, PhD, an instructor in the Jin lab was recently awarded the Center of Regenerative Medicine’s hCTO microgrant. This microgrant will support his research into congenital hydrocephalus (CH), a developmental brain disorder characterized by abnormal cerebrospinal fluid accumulation.
Ting Wang, PhD and researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy (Links to an external site)
Researchers at WashU Medicine have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack.